Growth in the cell isolation market is mainly driven by the growing government funding for cell-based research, increasing number of patients suffering from cancer and infectious diseases, technological advancements, and the growing focus on personalized medicine.
The study involved four major activities to estimate the current market size for the global cell isolation market. Exhaustive secondary research was done to collect information on the market and its different subsegments.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell isolation market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# The key players in the industry and markets have been identified through extensive secondary research.
# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Biotechnology & biopharmaceutical companies to hold the largest share of the market during the forecast period.
Based on end users, the cell isolation market is segmented into research laboratories & institutes, hospitals & diagnostic laboratories, biotechnology & biopharmaceutical companies, and other end users. The biotechnology & biopharmaceutical companies segment accounted for the largest market share in 2018. The large share of this segment is attributed to the widespread adoption of advanced instruments in cell-based experiments and cancer research in biotechnology & biopharmaceutical companies and the increasing number of R&D facilities globally.
Recent Developments:
# In 2017, Beckman Coulter launched CytoFLEX Flow Cytometry.
# In 2017, Miltenyi Biotec launched MultiMACS X Device
# In 2017, MilliporeSigma entered into a partnership with Public Health England to distribute the European Bank of Induced Pluripotent Stem Cells (EBiSC)
# In 2016, Becton, Dickinson and Company (BD) launched BD FACSymphony
North America held the largest share of the market in 2018.
The cell isolation market is segmented into four major geographic segments North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America commanded the largest share of the cell isolation market, followed by Europe. The large share of the North American market is attributed to technological advancements, growth in the biotechnology and pharmaceutical industries, increasing prevalence of chronic and infectious diseases, and higher investments in cell-based research in the region.
Request Sample Pages@
The key strategies followed by most companies in the cell isolation market are product launches, expansions, agreements, and acquisitions to achieve growth in the cell isolation market. The product launches accounted for the largest share of the overall growth strategies adopted from 2015 to 2018.
Key questions addressed in the report:
# What are the growth opportunities offered by the cell isolation market across major regions in the next five years?
# Emerging countries have immense opportunities for growth in the cell isolation market. Will this scenario continue during the next five years?
# How will advancements in products offered by various companies affect the market scenario in the mid- to long-term?
# What are the new trends and advancements in the cell isolation market?
The major players in the cell isolation market are Beckman Coulter (US), Becton Dickinson and Company (US), GE Healthcare (US), Merck KgaA (Germany), Miltenyi Biotec (Germany), pluriSelect (Germany), STEMCELL Technologies Inc. (Canada), Terumo BCT (US), Thermo Fisher Scientific (US), and Bio-Rad Laboratories Inc. (US).
No comments:
Post a Comment